Listing #5200884 oncnursingnews.com
249
The FDA granted a priority review for a Biologics License Application (BLA) to
bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...
Category
Website Performance
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedLoadTs | 509420823604 |
| interactive | 6.72 Sec |
| observedTraceEndTs | 509425801900 |
| firstContentfulPaint | 0.71 Sec |
| observedFirstMeaningfulPaint | 1.11 Sec |
| observedCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintAllFrames | 0.29 Sec |
| cumulativeLayoutShift | 0 Sec |
| observedLastVisualChangeTs | 509423354946 |
| observedTraceEnd | 7.82 Sec |
| maxPotentialFID | 0.18 Sec |
| observedTimeOrigin | 0 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| observedDomContentLoadedTs | 509418195375 |
| observedDomContentLoaded | 0.22 Sec |
| observedFirstMeaningfulPaintTs | 509419082777 |
| observedFirstVisualChange | 0.39 Sec |
| observedFirstContentfulPaintTs | 509418269367 |
| observedFirstVisualChangeTs | 509418371946 |
| totalBlockingTime | 0.36 Sec |
| observedNavigationStart | 0 Sec |
| observedLargestContentfulPaintAllFramesTs | 509419082777 |
| largestContentfulPaint | 4.48 Sec |
| observedLastVisualChange | 5.38 Sec |
| observedNavigationStartTs | 509417977946 |
| observedSpeedIndexTs | 509419932388 |
| observedFirstContentfulPaint | 0.29 Sec |
| observedLargestContentfulPaintTs | 509419082777 |
| firstMeaningfulPaint | 2.09 Sec |
| observedFirstPaint | 0.29 Sec |
| totalCumulativeLayoutShift | 0 Sec |
| observedTimeOriginTs | 509417977946 |
| observedLoad | 2.85 Sec |
| observedFirstContentfulPaintAllFramesTs | 509418269367 |
| speedIndex | 3.05 Sec |
| observedSpeedIndex | 1.95 Sec |
| observedLargestContentfulPaint | 1.11 Sec |
| observedFirstPaintTs | 509418269367 |
| observedLargestContentfulPaintAllFrames | 1.11 Sec |
| observedTotalCumulativeLayoutShift | 0 Sec |
